Enter your terms above and click the 'Search' button.

Showing articles 0 to 10 of 10 Filter Applied: Pittsburgh Compound B (Click to remove) Subjective Cognition and Amyloid Deposition Imaging Arch Neurol 69:223-229, Perrotin,A.,et al, 2012 Predicting sites of New Hemorrhage with Amyloid Imaging in Cerebral Amyloid Angiopathy Neurol 79:320-326, Gurol, M.E.,et al, 2012 Longitudinal Assessment of A-beta and Cognition in Aging and Alzheimer Disease Ann Neurol 69:181-192, Villemagne,V.L.,et al, 2011 Mild Cognitive Impairment NEJM 362:2227-2234, Peterson, R.C., 2011 In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009 Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study Neurol 73:754-760, 744, Okello,A.,et al, 2009 Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease Arch Neurol 66:1469-1475, Morris,J.,et al, 2009 Assessment of �-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography with Carbon 11-Labeled Pittsburgh Compound B Arch Neurol 65:1304-1309,1281, Leinonen,V.,et al, 2008 Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008 Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy Ann Neurol 62:229-234, Johnson,K.A.,et al, 2007 Showing articles 0 to 10 of 10